IMVARIA
imvaria was founded in 2019 by a team of physician-engineers from Stanford and Google, seeking to empower clinicians and improve patient outcomes through the development and application of modern computer science techniques to complex and serious diseases. The company's Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning. imvaria's lead software effort is assigned FDA's Breakthrough Device Designation.
IMVARIA
Industry:
Health Care Health Diagnostics Medical Device
Founded:
2019-01-01
Address:
Mountain View, California, United States
Country:
United States
Website Url:
http://www.imvaria.com
Total Employee:
11+
Status:
Active
Contact:
(650) 683-9800
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag IPv6 US Privacy User Signal Mechanism Google Cloud Storage
Similar Organizations
iXensor
The pioneer of mobile health
Vitara Biomedical
Vitara Biomedical develops a therapeutic platform to support premature infants.
Current Employees Featured
Founder
Investors List
Creative Ventures
Creative Ventures investment in Seed Round - imvaria
Cloudstone Venture
Cloudstone Venture investment in Seed Round - imvaria
Kevin Moore
Kevin Moore investment in Seed Round - imvaria
John Capodilupo
John Capodilupo investment in Seed Round - imvaria
InHealth Ventures
InHealth Ventures investment in Seed Round - imvaria
Meridian Street Capital
Meridian Street Capital investment in Seed Round - imvaria
Official Site Inspections
http://www.imvaria.com Semrush global rank: 2.81 M Semrush visits lastest month: 5.77 K
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "imvaria"
IMVARIA
Berkeley, Calif. โ April 18, 2023 โ IMVARIA Inc., a software-as-medical-device (SaMD) company pioneering AI-driven digital biomarker solutions, today announced that four presentations โฆSee details»
IMVARIA - Crunchbase Company Profile & Funding
IMVARIA serves Fibresolve -- the first AI diagnostic tool in interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF). Fibresolve is an FDA โฆSee details»
IMVARIA - LinkedIn
IMVARIA is advancing noninvasive AI biomarkers for better patient lives. We bring artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases.See details»
Imvaria 2025 Company Profile: Valuation, Funding
Imvaria General Information Description. Developer of a digital biomarker designed to enhance patient outcomes. The company's digital biomarkers use modern computer science techniques for solving complex and serious clinical โฆSee details»
IMVARIA INC. Company Profile | Berkeley, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IMVARIA INC. of Berkeley, CA. Get the latest business insights from Dun & Bradstreet.See details»
Imvaria - 2025 Company Profile, Funding & Competitors - Tracxn
5 days ago Imvaria is a funded company based in Mountain View (United States), founded in 2019. It operates as a Provider of AI-based data management device for doctors. The โฆSee details»
IMVARIA - Funding, Financials, Valuation & Investors - Crunchbase
IMVARIA brings artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases. ... Experience the new Crunchbase, powered by AI . Organization. IMVARIA โฆSee details»
IMVARIA - Contacts, Employees, Board Members, Advisors & Alumni
IMVARIA brings artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. โฆSee details»
imvaria - Products, Competitors, Financials, Employees, โฆ
IMVARIAโs AI-powered tools are reshaping the way serious lung diseases are detected and diagnosed, giving patients like Laura, Nick, and many others a clearer path forward. By โฆSee details»
imvaria inc. - VentureRadar
Imvaria is a health-tech company working to enable data-driven clinical decision-making through development and commercialization of its proprietary platform: the digital biomarker platform. โฆSee details»
imvaria Company Profile: Funding, Investors & Partnerships
Imvaria was founded in 2019 by a team of physician-engineers from Stanford and Google, seeking to empower clinicians and improve patient outcomes through the development and โฆSee details»
Imvaria - Overview, News & Similar companies | ZoomInfo.com
IMVARIA Announces Data Demonstrating Companyโs Non-Invasive Digital Biomarker for Predicting Mortality in Interstitial Lung Diseases BERKELEY, Calif.--(BUSINESS WIRE)-- โฆSee details»
Behind IMVARIA: how the Digital Biomarkers Lab was launched
Oct 10, 2022 Joshua Reicher, M.D. and Michael C. Muelly, M.D. co-founded IMVARIA, which operates its Digital Biomarker Lab with automated, machine-learning algorithm technology to โฆSee details»
Imvaria - Berkeley Startup Cluster
Developer of digital biomarkers designed to enhance patient outcomes. The companyโs digital biomarkers use modern computer science techniques for solving complex and serious clinical โฆSee details»
imvaria - UCSF Rosenman Institute
Jan 23, 2025 imvaria is a healthtech company developing and commercializing digital biomarkers, machine-learning driven tools to drive diagnosis and risk stratification in serious โฆSee details»
imvaria - Endless Frontier Labs
Imvaria provides digital biomarker solutions driven by artificial intelligence to solve challenging diagnostic problems in serious and rare diseases for clinicians, providing financial value to โฆSee details»
Fibresolve | The first FDA-authorized AI diagnostic tool in IPF
Berkeley, Calif. โ April 18, 2023 โ IMVARIA Inc., a software-as-medical-device (SaMD) company pioneering AI-driven digital biomarker solutions, today announced that four presentations โฆSee details»
IMVARIA - Crunchbase
Organization. IMVARIA . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. โฆSee details»
Imvaria - Taiwan Tech Arena๏ฝEmpowering Global Tech Startups
IMVARIA's lead digital biomarker, Fibresolve, demonstrates the power of IMVARIA's innovation to serve as adjunct in assessment of interstitial lung disease (ILD) including idiopathic pulmonary โฆSee details»
IMVARIA helps patients with interstitial lung disease and idiopathic ...
Feb 26, 2025 MedTech Alum โ21 IMVARIA brings artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious lung diseases. Fibresolve and ScreenDx are the โฆSee details»